Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Q-linea AB ( (SE:QLINEA) ) just unveiled an announcement.
Q-linea AB announced the successful exercise of 91.5% of its series TO1 warrants, resulting in the subscription of nearly 2 billion new shares at SEK 0.03 each, raising approximately 59.5 MSEK before transaction costs. This exercise increases the company’s share capital significantly and results in a dilution effect of about 30.8%, impacting the company’s financial structure and market positioning.
More about Q-linea AB
Q-linea AB is a company listed on Nasdaq Stockholm, primarily operating in the biotechnology industry. The company focuses on developing and providing innovative diagnostic solutions, particularly in the field of infectious diseases.
Average Trading Volume: 39,558,278
Current Market Cap: SEK204.2M
See more insights into QLINEA stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue